Ling Bi
Impact in
-
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
- Flavonoids in Medical Research
Papers in
-
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 4
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Sadanobu Kagamimori (2 shared papers)Lijing Jiao (14 shared papers)Xiulan Su (1 shared paper)Toyomi Kuwamori (1 shared paper)Ling Xu (13 shared papers)Yabin Gong (10 shared papers)Jialin Yao (7 shared papers)Yan Lu (3 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)Biological Procedures Online (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Amino Acids (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaAustraliaSouth Korea
In The Last Decade
Ling Bi
26 papers receiving 559 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 100
- Pharmacology 54
- Cell Biology 100
- Complementary and alternative medicine 45
- Pharmacology 88
Countries citing papers authored by Ling Bi
This map shows the geographic impact of Ling Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Bi more than expected).
Fields of papers citing papers by Ling Bi
This network shows the impact of papers produced by Ling Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Bi. The network helps show where Ling Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 157 | |
| 2 | 2018 | 46 | |
| 3 | 2022 | 42 | |
| 4 | 2019 | 41 | |
| 5 | 2020 | 29 | |
| 6 | 2014 | 26 | |
| 7 | 2018 | 25 | |
| 8 | 2021 | 24 | |
| 9 | 2019 | 24 | |
| 10 | 2018 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2017 | 18 | |
| 13 | 2020 | 16 | |
| 14 | 2003 | 15 | |
| 15 | 2019 | 13 | |
| 16 | 2022 | 11 | |
| 17 | 2020 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2022 | 5 | |
| 20 | 2024 | 4 |
About Ling Bi
Ling Bi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pharmacology, having authored 29 papers that have together received 569 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), RNA modifications and cancer (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Flavonoids in Medical Research (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (3 papers), Lung Cancer Research Studies (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (100 citations), Pharmacology (54 citations), Cell Biology (100 citations), Complementary and alternative medicine (45 citations) and Pharmacology (88 citations). Ling Bi has collaborated with scholars based in China, Australia and South Korea. Frequent co-authors include Sadanobu Kagamimori, Lijing Jiao, Xiulan Su, Toyomi Kuwamori, Ling Xu, Yabin Gong, Jialin Yao, Yan Lu, Qihan Dong and Wenxiao Yang. Their work appears in journals such as Frontiers in Pharmacology, Biological Procedures Online, Journal of Cellular and Molecular Medicine, Amino Acids and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.